Period17 Dec 2018

Media coverage

1

Media coverage

  • TitleVedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date17/12/18
    PersonsJeremiah Faith